Related Experiment Video
Updated: May 30, 2026

Temporal Quantification of MAPK Induced Expression in Single Yeast Cells
Published on: October 4, 2013
Live-cell microscopy reveals small molecule inhibitor effects on MAPK pathway dynamics
Daniel J Anderson1, Jenni K Durieux, Kyung Song
1Department of Cell Regulation, Genentech, Inc, South San Francisco, California, United States of America.
Abstract:
Oncogenic mutations in the mitogen activated protein kinase (MAPK) pathway are prevalent in human tumors, making this pathway a target of drug development efforts. Recently, ATP-competitive Raf inhibitors were shown to cause MAPK pathway activation via Raf kinase priming in wild-type BRaf cells and tumors, highlighting the need for a thorough understanding of signaling in the context of small molecule kinase inhibitors. Here, we present critical improvements in cell-line engineering and image analysis coupled with automated image acquisition that allow for the simultaneous identification of cellular localization of multiple MAPK pathway components (KRas, CRaf, Mek1 and Erk2). We use these assays in a systematic study of the effect of small molecule inhibitors across the MAPK cascade either as single agents or in combination. Both Raf inhibitor priming as well as the release from negative feedback induced by Mek and Erk inhibitors cause translocation of CRaf to the plasma membrane via mechanisms that are additive in pathway activation. Analysis of Erk activation and sub-cellular localization upon inhibitor treatments reveals differential inhibition and activation with the Raf inhibitors AZD628 and GDC0879 respectively. Since both single agent and combination studies of Raf and Mek inhibitors are currently in the clinic, our assays provide valuable insight into their effects on MAPK signaling in live cells.
Insights
Small molecule kinase inhibitors targeting the mitogen-activated protein kinase (MAPK) pathway can paradoxically activate it. Our study reveals how Raf and Mek inhibitors affect MAPK signaling and CRaf localization in live cells.
Area of Science:
- Cellular biology
- Molecular oncology
- Drug discovery
Background:
- The mitogen-activated protein kinase (MAPK) pathway is frequently altered in human cancers, making it a key target for therapeutic interventions.
- Recent findings indicate that ATP-competitive Raf inhibitors can paradoxically activate the MAPK pathway through Raf kinase priming, necessitating a deeper understanding of signaling dynamics under inhibitor treatment.
- Understanding these complex signaling events is crucial for developing effective targeted therapies.
Purpose of the Study:
- To develop and apply advanced live-cell imaging assays for simultaneous tracking of multiple MAPK pathway components (KRas, CRaf, Mek1, Erk2).
- To systematically investigate the effects of small molecule inhibitors on MAPK signaling, both as single agents and in combination.
- To elucidate the mechanisms underlying MAPK pathway activation and CRaf translocation induced by Raf and Mek inhibitors.
Main Methods:
- Utilized improved cell-line engineering, automated image acquisition, and advanced image analysis techniques.
- Developed assays for simultaneous identification and localization of KRas, CRaf, Mek1, and Erk2 within live cells.
- Conducted systematic studies on the impact of various small molecule inhibitors on MAPK pathway components.
Main Results:
- Observed that both Raf inhibitor priming and the release from negative feedback by Mek/Erk inhibitors promote CRaf translocation to the plasma membrane through additive mechanisms.
- Demonstrated differential inhibition and activation of Erk by Raf inhibitors AZD628 and GDC0879, respectively, based on activation and subcellular localization.
- Showcased the additive nature of pathway activation mechanisms induced by Raf and Mek/Erk inhibitors.
Conclusions:
- The developed live-cell assays provide valuable insights into MAPK signaling dynamics in response to small molecule inhibitors.
- Findings highlight the complex interplay of pathway components and feedback loops under inhibitor pressure.
- These assays are critical for evaluating the efficacy of current and future MAPK-targeted therapies, including combination strategies.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
07:14Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
Published on: September 20, 2019
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...